Omada Health, Inc. $OMDA Shares Acquired by Renaissance Technologies LLC

Renaissance Technologies LLC lifted its stake in Omada Health, Inc. (NASDAQ:OMDA) by 173.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 391,069 shares of the company’s stock after buying an additional 248,269 shares during the period. Renaissance Technologies LLC’s holdings in Omada Health were worth $4,916,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of OMDA. Quarry LP purchased a new position in Omada Health in the fourth quarter worth $29,000. TD Waterhouse Canada Inc. purchased a new stake in shares of Omada Health during the 4th quarter worth $32,000. Raymond James Financial Inc. acquired a new position in shares of Omada Health during the 2nd quarter worth $32,000. Inlight Wealth Management LLC purchased a new position in shares of Omada Health in the 4th quarter valued at about $45,000. Finally, Strs Ohio boosted its holdings in Omada Health by 151.0% during the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock worth $67,000 after buying an additional 2,567 shares in the last quarter.

Insider Buying and Selling

In other Omada Health news, CFO Steven L. Cook sold 12,337 shares of the stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $23.09, for a total transaction of $284,861.33. Following the transaction, the chief financial officer owned 187,209 shares of the company’s stock, valued at $4,322,655.81. This trade represents a 6.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Craig Gracey sold 2,083 shares of Omada Health stock in a transaction on Monday, June 29th. The shares were sold at an average price of $21.00, for a total transaction of $43,743.00. Following the completion of the transaction, the chief accounting officer owned 858 shares in the company, valued at approximately $18,018. This trade represents a 70.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 206,406 shares of company stock valued at $4,191,483. Insiders own 6.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Wells Fargo & Company boosted their price target on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research note on Monday, July 20th. BTIG Research assumed coverage on Omada Health in a research report on Friday, July 17th. They set a “buy” rating and a $30.00 target price on the stock. Morgan Stanley reissued an “overweight” rating and issued a $30.00 target price on shares of Omada Health in a report on Monday, June 22nd. Finally, Wall Street Zen cut Omada Health from a “buy” rating to a “hold” rating in a research report on Saturday, July 18th. Eleven equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $24.75.

Omada Health Stock Up 2.3%

Shares of NASDAQ:OMDA opened at $19.54 on Friday. The company has a market cap of $1.16 billion, a P/E ratio of -72.37 and a beta of 1.73. The business has a fifty day simple moving average of $20.24 and a 200-day simple moving average of $16.15. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. Sell-side analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Omada Health News Roundup

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Quarterly results beat expectations. Omada reported adjusted earnings of $0.15 per share, up from a $0.09 loss a year earlier and above the $0.05 consensus estimate. Another earnings summary reported EPS of $0.08 versus an expected loss of $0.02, reinforcing that results exceeded forecasts. Omada Health Q2 earnings and revenues top estimates
• Positive Sentiment: Growth remained strong. Second-quarter revenue rose 43% year over year, while total members increased 45%. Gross margin also reached a new quarterly record, supporting the company’s growth and profitability narrative. Omada Health reports second-quarter 2026 results
• Positive Sentiment: Full-year revenue guidance exceeded Wall Street expectations. Omada forecast fiscal 2026 revenue of $334 million to $340 million, above the $327.2 million analyst consensus. This suggests management expects sustained demand for its digital chronic-care programs.
• Neutral Sentiment: Leadership transition adds an execution consideration. Co-founder and CEO Sean Duffy will become executive chair on January 1, 2027, while President Wei-Li Shao becomes CEO. The planned, internal succession may provide continuity, although investors will monitor whether the change affects growth execution.
• Negative Sentiment: CEO insider selling provided a modest counterpoint. Duffy sold 12,944 shares for approximately $264,000, reducing his direct ownership by 3.05%. While the sale may have been for personal or financial-planning reasons, insider selling can weigh on sentiment.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.